References
References Abstracts of some medical references can be obtained on the web. Go to www.bmj.com, click on “medline,” and click on “National Library of Medicine.” Search engines will produce a complete copy of an increasingly large number of papers.
1. Abajian, J.C., Page, P., Morgan, M. (1973) “Effects of droperidol and nitrazepam on emergence reactions following ketamine anesthesia,” Anesthesia and Analgesia; Current Researches 52: 385–389. 2. Abi-Saab, W.M., D’Souza, D.C., Moghaddam, B., Krystal, J.H. (1998) “The NMDA antagonist model for schizophrenia: promise and pitfalls,” Pharmacopsychiatry 31 Supplement 2: 104–109. 3. Abramson, H.A. (Ed.) (1967) The Use of LSD in Psychotherapy and Alcoholism, Bobbs-Merrill, New York. 4. Adamec, R. (1997) “Transmitter systems involved in neural plasticity underlying increased anxiety and defense: implications for understanding anxiety following traumatic stress,” Neuroscience and Biobehavioural Reviews 21(6): 755– 765. 5. Adams, D. (1992 [1986]) The Hitchhiker’s Guide to the Galaxy, Pan Books, London. 6. Adams, H.A., Thiel, A., Jung, A., Fengler, G., Hempelmann, G. (1992) “Studies using S- (+)-ketamine on probands. Endocrine and circulatory reactions, recovery and dream experiences,” Anesthetist 41: 588–596. 7. Aghajan, G.K. & G.J. Marek (2000) “Serotonin Model of Schizophrenia: Emerging Role of Glutamate Mechanisms,” Brain Res. Brain Res. Rev. 31(2/3): 302– 312. 8. Ahmed, S.N., Petchkovsky, L. (1980) “Abuse of ketamine,” British Journal of Psychiatry 137: 303. 9. Albin, M. et al. (1970) “Longterm personality evaluation in patients subjected to ketamine hydrochloride and other anesthetic agents,” Pharmacology: Abstracts of Scientific Papers. American Society of Anesthesiologists Annual Meeting, p 160. 10. Amzica, F. & M. Steriade (1998) “Cellular substrates and laminar profile of sleep K-complex,” Neuroscience 82 (3): 671–686. 11. Anand, A. Charney, D.S., Oren, D.A., Berman, R.M., Hu, X.S., Cappiello, A., Krystal, J.H. (2000) “Attenuation of the Neuropsychiatric Effects of Ketamine and Lamotrigine: Support for Hyperglutamatergic Effects of N-methyl-Daspartate Receptor Antagonists,” Arch. Gen, Psychiatry 57(3)” 270–276. 12. Anis, N.A., Berry, S.C., Burton, N.R., Lodge, D. (1983) “The dissociative anaesthetics ketamine and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methyl-aspartate,” British Journal of Pharmacology 79: 565–575. 13. Anon. (1997) “Ketamine: The Hot New Drug of Abuse,” Forensic Drug Abuse Advisor 9(6), (FDAA@batnet.com). 14. Antal, M. (1971) “Ketamine-induced ultrastructural changes in the retina,” Albrecht Von Graefes Arch. Klin. Exp. Ophthalmology 210: 45–53.
302
15. Antal, M. & G. Musci (1984) “Effect of combined diazepam-ketamine anaesthesia on the ultrastructure of the retina,” Morphol. Igassagugyi. Orv. Sz. 24: 17–22. 16. Antal, M., Musci, G., Faludi, A. (1978) “Ketamine anaesthesia and intraocular pressure,” Annals of Opthalmology 10: 1281–1289. 17. Appadu, B., Calder, I. (1991) “Ketamine does not always work in treatment of priapism,” Anaesthesia 46: 426–427. 18. Arvanov, V.L., Wang, R.Y. (1998) “M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-Daspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro,” Neuropsychopharmacology 18(3): 197–209. 19. Auer, R.N. (1994) “Assessing structural changes in the brain to evaluate neurotoxicologic effects of NMDA receptor antagonists,” Psychopharmacology Bulletin 30(4): 585–591. 20. Auer, R.N. (1996) “Effect of age and sex on N-methyl-D-aspartate antagonistinduced neuronal necrosis in rats,” Stroke 27(4): 743–746. 21. Auer, R.N. (1998) Personal communication. 22. Auer, R.N. et al. (1996) “Postischaemic therapy with MK-801 (dizocilpine) in a primate model of transient focal brain ischaemia,” Molecular and Chemical Neuropathology 29(2–3): 193–210. 23. Ayala, F.J. (1995) “The myth of Eve: molecular biology and human origins,” Science 270(5244): 1930–1936. 24. Bailey, L.W. & J. Yates (Eds.) (1996) The Near-death Experience—A Reader, Routledge, London. 25. Barker, J.L. et al. (1978) “Opiate peptide modulation of amino acid responses suggests novel form of neuronal communication,” Science 199: 1451–1453. 26. Battaglia, G., Yeh, S.Y., De Souza, E.B. (1988) “MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons,” Pharmacology, Biochemistry and Behavior 29: 269–274. 27. Beardsley, P.M. & R.L. Balster (1987) “Behavioral dependence upon phencyclidine and ketamine in the rat,” Journal of Pharmacology and Experimental Therapeutics 242: 203–211. 28. Bell, D.S. (1965) “Comparison of amphetamine psychosis and schizophrenia,” British Journal of Psychiatry 111: 701–707. 29. Bell, J.S. (1987) Speakable and Unspeakable in Quantum Mechanics. Cambridge University Press. 30. Bellos, A. (1997) “The media and Ecstasy.” In: Saunders, N.E. (Ed.) (1997) Ecstasy Reconsidered, Neal’s Yard Desk Top Publishing Studio, London, pp 28– 35. 31. Benveniste, H. et al. (1984) “Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during cerebral ischaemia monitored by microdialysis,” Journal of Neurochemistry 43: 1369–1374. 32. Bergman, S.A. (1999) “Ketamine: review of its pharmacology and its use in pediatric anesthesia,” Anesthesia Progress 46(1): 10–20. 33. Berman, R.M., Cappiello, A., Anand, A., Oren, D.A., Heninger, G.R., Charney, D.S., Krystal, J.H. (2000) “Antidepressant Effects of Ketamine in Depressed Patients,” Biol. Psychiatry 47(4): 351–354. 34. Bexton, W.H. et al. (1954) “Effects of decreased variation in the sensory environment,” Canadian Journal of Psychology 8: 70–76.
303